SadakaYVerheyLHShroffMM. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol2012; 72: 211–223.
2.
TantsisEMPrelogKBrilotF. Risk of multiple sclerosis after a first demyelinating syndrome in an Australian Paediatric cohort: clinical, radiological features and application of the McDonald 2010 MRI criteria. Mult Scler2013Apr11. [Epub ahead of print].
3.
KornekBSchmitlBVassK. Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome. Mult Scler2012; 18: 1768–1774.
4.
BanwellBBar-OrAArnoldDL. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol2011; 10: 436–445.
5.
KruppLBTardieuMAmatoMP. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler2013Apr9. [Epub ahead of print; PMID: 23572237].
6.
RenouxCVukusicSMikaeloffY. Natural history of multiple sclerosis with childhood onset. N Engl J Med2007; 356: 2603–2613.
7.
BanwellBBar-OrAGiovannoniG. Therapies for multiple sclerosis: considerations in the pediatric patient. Nat Rev Neurol2011; 7: 109–122.
8.
BrilotFDaleRCSelterRC. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann Neurol2009; 66: 833–842.
9.
McLaughlinKAChitnisTNewcombeJ. Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J Immunol2009; 183: 4067–4076.